Literature DB >> 14732352

Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats.

Trent M Woodruff1, Thiruma V Arumugam, Ian A Shiels, Robert C Reid, David P Fairlie, Stephen M Taylor.   

Abstract

OBJECTIVES: The capacity of a potent C5a receptor antagonist to inhibit various parameters of local and remote organ injury following lower limb ischemia-reperfusion (I/R) in rats was investigated.
METHODS: Rats were subjected to 2 h bilateral hindlimb ischemia and 4 h reperfusion. Drug-treated rats received AcF-[OPdChaWR] (1 mg/kg) iv either 10 min before ischemia or 10 min prior to reperfusion, or orally (10 mg/kg) 30 min prior to ischemia. Levels of circulating creatine kinase (CK), lactate dehydrogenase (LDH), alanine and aspartate aminotransferase (ALT/AST), creatinine, blood urea nitrogen (BUN), polymorphonuclear leukocytes (PMNs), and calcium (Ca(++)) and potassium (K(+)) ions were determined. Other parameters measured included urinary protein levels, muscle edema, and myeloperoxidase (MPO) concentrations in the lung, liver, and muscle along with liver homogenate tumor necrosis factor-alpha (TNF-alpha) concentrations.L
RESULTS: imb I/R injury was characterized by significant elevations of CK, LDH, ALT, AST, creatinine, BUN, proteinuria, PMNs, serum K(+), muscle edema, organ MPO, and liver homogenate TNF-alpha concentrations, but a significant reduction in serum Ca(2+) concentrations. When rats were treated with AcF-[OPdChaWR], there were significant improvements in all these parameters.
CONCLUSIONS: These results indicate a pivotal role for C5a in inducing local and remote organ injury and suggest a possible new drug therapeutic category for preventing anticipated tissue injury associated with I/R.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732352     DOI: 10.1016/j.jss.2003.04.001

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  28 in total

1.  Effect of thymoquinone, a constituent of Nigella sativa L., on ischemia-reperfusion in rat skeletal muscle.

Authors:  Hossein Hosseinzadeh; Samaneh Taiari; Marjan Nassiri-Asl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-22       Impact factor: 3.000

Review 2.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

3.  Anaphylatoxins in preterm and term labor.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Jyh Kae Nien; Tinnakorn Chaiworapongsa; Joaquin Santolaya-Forgas; Samuel S Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2005       Impact factor: 1.901

4.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

5.  Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model.

Authors:  Antonio Pinto; Annika Jahn; Moritz Benjamin Immohr; Alexander Jenke; Laura Döhrn; Markus Kornfeld; Artur Lichtenberg; Payam Akhyari; Udo Boeken
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

6.  Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.

Authors:  Esther Sok Hwee Cheow; Woo Chin Cheng; Chuen Neng Lee; Dominique de Kleijn; Vitaly Sorokin; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2016-05-27       Impact factor: 5.911

7.  Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat.

Authors:  Q Dong; L Sun; L Peng; B Yan; J Lv; G Wang; S Gong
Journal:  Spinal Cord       Date:  2015-04-28       Impact factor: 2.772

8.  Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury.

Authors:  Dongwon Lee; Soochan Bae; Qingen Ke; Jiyoo Lee; Byungjoo Song; S Ananth Karumanchi; Gilson Khang; Hak Soo Choi; Peter M Kang
Journal:  J Control Release       Date:  2013-10-02       Impact factor: 9.776

9.  Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.

Authors:  Alok S Pachori; Luis G Melo; Melanie L Hart; Nicholas Noiseux; Lunan Zhang; Fulvio Morello; Scott D Solomon; Gregory L Stahl; Richard E Pratt; Victor J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

10.  Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury.

Authors:  Xiufen Zheng; Xusheng Zhang; Biao Feng; Hongtao Sun; Motohiko Suzuki; Thomas Ichim; Norihiko Kubo; Arthur Wong; Lisa R Min; Marianne E Budohn; Bertha Garcia; Anthony M Jevnikar; Wei-Ping Min
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.